Meclophenamic acid en es it fr

Meclophenamic acid Brand names, Meclophenamic acid Analogs

Meclophenamic acid Brand Names Mixture

  • No information avaliable

Meclophenamic acid Chemical_Formula

C5H4N4S

Meclophenamic acid RX_link

http://www.rxlist.com/cgi/generic2/mercaptopurine.htm

Meclophenamic acid fda sheet

Meclophenamic_acid FDA

Meclophenamic acid msds (material safety sheet)

Meclophenamic_acid MSDS

Meclophenamic acid Synthesis Reference

No information avaliable

Meclophenamic acid Molecular Weight

152.178 g/mol

Meclophenamic acid Melting Point

313 oC

Meclophenamic acid H2O Solubility

6.85 mg/mL

Meclophenamic acid State

Solid

Meclophenamic acid LogP

0.335

Meclophenamic acid Dosage Forms

Tablet (50-mg, scored) for oral administration

Meclophenamic acid Indication

For remission induction and maintenance therapy of acute lymphatic leukemia.

Meclophenamic acid Pharmacology

Mercaptopurine is one of a large series of purine analogues which interfere with nucleic acid biosynthesis and has been found active against human leukemias. It is an analogue of the purine bases adenine and hypoxanthine. It is not known exactly which of any one or more of the biochemical effects of mercaptopurine and its metabolites are directly or predominantly responsible for cell death.

Meclophenamic acid Absorption

Clinical studies have shown that the absorption of an oral dose of mercaptopurine in humans is incomplete and variable, averaging approximately 50% of the administered dose. The factors influencing absorption are unknown.

Meclophenamic acid side effects and Toxicity

Signs and symptoms of overdosage may be immediate such as anorexia, nausea, vomiting, and diarrhea; or delayed such as myelosuppression, liver dysfunction, and gastroenteritis. The oral LD50 of mercaptopurine was determined to be 480 mg/kg in the mouse and 425 mg/kg in the rat.

Meclophenamic acid Patient Information

No information avaliable

Meclophenamic acid Organisms Affected

Humans and other mammals